Choose a language and wait for the translated text.
Apollo funds and affiliates would take a minority, non-controlling stake in a new entity holding the LARC business, while Bayer keeps a majority stake and "complete operational control."
Bayer gets €3 billion in Apollo deal for contraceptives unit | PharmaVoice
